China Grand Prosperity Investment

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Sep 21, 2023	LYNK Pharmaceuticals	$44.1M Series C	China Grand Prosperity Investment	Lilly Asia Ventures, New Alliance Capital
Jun 1, 2023	LYNK Pharmaceuticals	$28.1M Series C	—	Liando Investment

Total Raised

N/A

Valuation

N/A